Gainers
- CERo Therapeutics Hldgs CERO stock rose 175.6% to $0.19 during Monday's pre-market session. The market value of their outstanding shares is at $28.9 million.
- Nuwellis NUWE shares increased by 27.07% to $2.3. The company's market cap stands at $4.2 million. As per the press release, Q3 earnings came out today.
- RadNet RDNT shares increased by 22.7% to $89.0. The market value of their outstanding shares is at $6.5 billion. The company's, Q3 earnings came out today.
- Revelation Biosciences REVB shares increased by 21.95% to $1.0. The company's market cap stands at $3.7 million. As per the press release, Q3 earnings came out yesterday.
- Vigil Neuroscience VIGL shares increased by 21.28% to $4.33. The market value of their outstanding shares is at $171.6 million. As per the press release, Q3 earnings came out 2 days ago.
- Evotec EVO shares increased by 19.37% to $4.93. The company's market cap stands at $1.7 billion. As per the news, the Q3 earnings report came out 3 days ago.
Losers
- RAPT Therapeutics RAPT shares declined by 48.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $52.3 million.
- Fresh2 Group FRES shares decreased by 17.3% to $1.1. The company's market cap stands at $26.9 million.
- Tivic Health Systems TIVC shares declined by 15.55% to $0.34. The market value of their outstanding shares is at $2.1 million.
- Dogwood Therapeutics DWTX stock fell 13.73% to $3.71. The company's market cap stands at $4.9 million. As per the press release, Q3 earnings came out 2 days ago.
- AbbVie ABBV stock decreased by 10.68% to $178.2. The market value of their outstanding shares is at $314.6 billion.
- SenesTech SNES shares fell 8.46% to $2.6. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in